Algert Global’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Algert Global’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-21,393	Closed	-$1.46M	–	1349
2022 Q3	$1.46M	Sell	21,393 -18,408	-46%	-$1.02M	0.09%	394
2022 Q2	$1.27M	Buy	39,801 +14,203	+55%	+$416K	0.1%	375
2022 Q1	$887K	Buy	25,598 +12,413	+94%	+$371K	0.06%	575
2021 Q4	$386K	Buy	+13,185	New	+$408K	0.05%	638

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Algert Global's GBT Position: Q4 2022 in Review

Algert Global sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 21,393 shares — an estimated $1.46M sold.

Algert Global first reported a position in GBT in Q4 2021 and held it in 4 quarters. The position peaked at $1.46M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Algert Global reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Algert Global sold 21,393 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $1.46M.
Algert Global first reported a position in Global Blood Therapeutics, Inc. in Q4 2021 and held it in 4 quarters.
Algert Global's Global Blood Therapeutics, Inc. position peaked at $1.46M in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Algert Global's 13F filing for Q4 2022, filed 14 Feb 2023.